Ordaos Bio

Ordaōs Bio is a privately held company based in New York, New York. With 31 employees, the company focuses on innovative solutions in the biotechnology sector. Ordaōs Bio specializes in developing miniPRO™ proteins that are utilized in drug design. These proteins assist drug developers in creating safer and more effective treatments compared to conventional drug discovery methods. Their target customers are within the pharmaceutical and biotechnology industries. The company distinguishes itself through its unique approach to drug design, leveraging a combination of human expertise and machine learning. This human-enabled, machine-driven methodology aims to accelerate the development of novel and impactful therapies. For more information about Ordaōs Bio and its groundbreaking protein technology, please visit their website at ordaos.bio.